文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

亚洲年轻乳腺癌的多组学特征分析揭示了独特的分子特征。

Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.

机构信息

Pfizer Oncology Research, San Diego, CA, 92121, USA.

Samsung Genome Institute, Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.

出版信息

Nat Commun. 2018 Apr 30;9(1):1725. doi: 10.1038/s41467-018-04129-4.


DOI:10.1038/s41467-018-04129-4
PMID:29713003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5928087/
Abstract

Breast cancer (BC) in the Asia Pacific regions is enriched in younger patients and rapidly rising in incidence yet its molecular bases remain poorly characterized. Here we analyze the whole exomes and transcriptomes of 187 primary tumors from a Korean BC cohort (SMC) enriched in pre-menopausal patients and perform systematic comparison with a primarily Caucasian and post-menopausal BC cohort (TCGA). SMC harbors higher proportions of HER2+ and Luminal B subtypes, lower proportion of Luminal A with decreased ESR1 expression compared to TCGA. We also observe increased mutation prevalence affecting BRCA1, BRCA2, and TP53 in SMC with an enrichment of a mutation signature linked to homologous recombination repair deficiency in TNBC. Finally, virtual microdissection and multivariate analyses reveal that Korean BC status is independently associated with increased TIL and decreased TGF-β signaling expression signatures, suggesting that younger Asian BCs harbor more immune-active microenvironment than western BCs.

摘要

亚太地区的乳腺癌(BC)患者以年轻患者居多,发病率迅速上升,但其分子基础仍知之甚少。在这里,我们分析了来自韩国 BC 队列(SMC)的 187 个原发性肿瘤的外显子组和转录组,该队列中绝经前患者较多,并与主要为高加索人和绝经后 BC 队列(TCGA)进行了系统比较。SMC 中 HER2+和 Luminal B 亚型的比例较高,Luminal A 亚型的比例较低,与 TCGA 相比,ESR1 表达降低。我们还观察到在 SMC 中,BRCA1、BRCA2 和 TP53 的突变发生率增加,与三阴性乳腺癌中同源重组修复缺陷相关的突变特征富集。最后,虚拟微观解剖和多变量分析表明,韩国 BC 状态与增加的 TIL 和减少的 TGF-β信号表达特征独立相关,这表明年轻的亚洲 BC 比西方 BC 具有更活跃的免疫微环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/3f90b8a715ff/41467_2018_4129_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/bf2c46b7de37/41467_2018_4129_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/f523b381be4b/41467_2018_4129_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/2fb5cc01c660/41467_2018_4129_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/0a72d695763d/41467_2018_4129_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/3f90b8a715ff/41467_2018_4129_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/bf2c46b7de37/41467_2018_4129_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/f523b381be4b/41467_2018_4129_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/2fb5cc01c660/41467_2018_4129_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/0a72d695763d/41467_2018_4129_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b624/5928087/3f90b8a715ff/41467_2018_4129_Fig5_HTML.jpg

相似文献

[1]
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.

Nat Commun. 2018-4-30

[2]
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.

Eur J Cancer. 2020-1-16

[3]
Relationship of the Breast Ductal Carcinoma Immune Microenvironment with Clinicopathological and Genetic Features.

Clin Cancer Res. 2017-6-13

[4]
[BRCA1- and BRCA2- associated breast carcinomas].

Pathologe. 2009-12

[5]
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor-Positive Breast Cancer Patients.

Clin Cancer Res. 2020-12-15

[6]
Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.

Cancer. 2014-2-12

[7]
Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.

Clin Breast Cancer. 2020-4

[8]
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.

Breast Cancer Res Treat. 2009-10-23

[9]
Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.

Biomed Res Int. 2020

[10]
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.

Fam Cancer. 2015-12

引用本文的文献

[1]
Differences in the distribution of HER2-positive breast tumors according to ethnicity and genetic variants in : a special focus on Asian and Latina women.

Front Oncol. 2025-7-24

[2]
Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline deletion: results of the phase II AUROR study.

Lancet Reg Health West Pac. 2025-7-13

[3]
Breast Cancer Information Grand Round for Survivorship (BIG-S) prospective cohort.

Eur J Epidemiol. 2025-7-8

[4]
Immunotherapy and its racial specificity for breast cancer treatment in Asia: a narrative review.

Lancet Reg Health West Pac. 2024-9-19

[5]
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).

Breast. 2025-5-12

[6]
A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables.

Brief Bioinform. 2025-3-4

[7]
Multi-omics insights into the roles of CCNB1, PLK1, and HPSE in breast cancer progression: implications for prognosis and immunotherapy.

Discov Oncol. 2025-4-5

[8]
Comprehensive germline and somatic profiling of high-risk Thai breast cancer via next-generation sequencing.

Sci Rep. 2025-4-3

[9]
Signaling pathway dysregulation in breast cancer.

Oncotarget. 2025-3-13

[10]
Equitable machine learning counteracts ancestral bias in precision medicine.

Nat Commun. 2025-3-10

本文引用的文献

[1]
Combined immune checkpoint blockade as a therapeutic strategy for -mutated breast cancer.

Sci Transl Med. 2017-6-7

[2]
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.

JAMA Oncol. 2017-12-1

[3]
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.

Genome Med. 2017-4-19

[4]
TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.

Diagn Pathol. 2017-2-2

[5]
Analysis of cancer genomes reveals basic features of human aging and its role in cancer development.

Nat Commun. 2016-8-12

[6]
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.

J Clin Oncol. 2016-8-1

[7]
The Ensembl Variant Effect Predictor.

Genome Biol. 2016-6-6

[8]
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.

Nat Commun. 2016-5-10

[9]
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature. 2016-6-2

[10]
The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database.

J Breast Cancer. 2016-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索